Strix Group share price “could bounce back as we get strong earnings this year “says Zeus Capital (LON:KETL) 10 February 2022
Cizzle Biotechnology commercial & royalty agreement represents a very significant deal for the company (LON:CIZ) 9 February 2022
Quadrise Fuels International test results will support and hopefully accelerate the plans on the larger scale trials (LON:QFI) 9 February 2022
Surface Transforms FY25 update: Revenue up 120% as manufacturing improvements progress 19 January 2026
Ferro-Alloy Resources agrees MOU with Master Tyre for new carbon black substitute supply 19 January 2026
JTC Group “delivering organic revenue growth at the top end of its guidance” says Zeus Capital 16 September 2020
SimplyBiz Group “to provide investors with higher than market earnings growth” says Zeus Capital 16 September 2020
City of London Investment Group results beat Zeus Capital’s revenue forecast by 4.1% 15 September 2020
Surface Transforms “well positioned to deliver for the medium-term” says Zeus Capital 15 September 2020
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Real Estate Credit Investments Gains Strong Shareholder Backing Following 2025 Continuation Vote (LON:RECI) 14 January 2026
FirstGroup PLC (FGP.L) Stock Analysis: Exploring a 35% Upside Potential with Strong Buy Ratings 20 January 2026
Auction Technology Group PLC (ATG.L) Stock Analysis: Navigating the 26.51% Upside Potential 20 January 2026
Hilton Food Group PLC (HFG.L) Investor Outlook: 52.39% Potential Upside Highlights Growth Prospects 20 January 2026
Baltic Classifieds Group PLC (BCG.L) Stock Analysis: Unlocking a Potential 41% Upside 20 January 2026
Strix Group share price “could bounce back as we get strong earnings this year “says Zeus Capital (LON:KETL) 10 February 2022
Cizzle Biotechnology commercial & royalty agreement represents a very significant deal for the company (LON:CIZ) 9 February 2022
Quadrise Fuels International test results will support and hopefully accelerate the plans on the larger scale trials (LON:QFI) 9 February 2022
Surface Transforms FY25 update: Revenue up 120% as manufacturing improvements progress 19 January 2026
Ferro-Alloy Resources agrees MOU with Master Tyre for new carbon black substitute supply 19 January 2026
JTC Group “delivering organic revenue growth at the top end of its guidance” says Zeus Capital 16 September 2020
SimplyBiz Group “to provide investors with higher than market earnings growth” says Zeus Capital 16 September 2020
City of London Investment Group results beat Zeus Capital’s revenue forecast by 4.1% 15 September 2020
Surface Transforms “well positioned to deliver for the medium-term” says Zeus Capital 15 September 2020
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Real Estate Credit Investments Gains Strong Shareholder Backing Following 2025 Continuation Vote (LON:RECI) 14 January 2026
FirstGroup PLC (FGP.L) Stock Analysis: Exploring a 35% Upside Potential with Strong Buy Ratings 20 January 2026
Auction Technology Group PLC (ATG.L) Stock Analysis: Navigating the 26.51% Upside Potential 20 January 2026
Hilton Food Group PLC (HFG.L) Investor Outlook: 52.39% Potential Upside Highlights Growth Prospects 20 January 2026
Baltic Classifieds Group PLC (BCG.L) Stock Analysis: Unlocking a Potential 41% Upside 20 January 2026
AnaptysBio, Inc. (ANAB) Investor Outlook: Exploring a 36.95% Potential Upside in the Biotech Sector 19 December 2025
Taysha Gene Therapies (TSHA) Stock Analysis: Biotech Innovator with 97.90% Upside Potential 19 December 2025
Intellia Therapeutics, Inc. (NTLA) Stock Analysis: Exploring a 152.61% Potential Upside in Gene Editing Revolution 19 December 2025
Neuropace, Inc. (NPCE) Stock Analysis: Unveiling a 22.3% Potential Upside in the Medical Device Sector 19 December 2025
Niagen Bioscience, Inc. (NAGE) Stock Analysis: A Biotech Gem with 143% Potential Upside 19 December 2025
Zymeworks Inc. (ZYME) Stock Analysis: A Promising Biotech Play with a 34.62% Upside Potential 19 December 2025
OrthoPediatrics Corp. (KIDS) Investor Outlook: Analysts Forecast 37% Upside Potential 19 December 2025
Dianthus Therapeutics, Inc. (DNTH): Investor Outlook on a Biotech with 51% Upside Potential 19 December 2025
CureVac N.V. (CVAC) Investor Outlook: Assessing a 26.20% Potential Upside in the Innovative mRNA Space 19 December 2025
Akso Health Group (AHG) Stock Analysis: Unpacking the 415.8% Revenue Growth in China’s Booming Healthcare Sector 19 December 2025
Syndax Pharmaceuticals, Inc. (SNDX) Stock Analysis: A 94.3% Upside Potential Amid Biotech Innovations 19 December 2025
Delcath Systems, Inc. (DCTH) Investor Outlook: A 124% Potential Upside in the Expanding Oncology Market 19 December 2025
Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Uncovering a 144.90% Potential Upside in the Biotech Arena 19 December 2025
iRadimed Corporation (IRMD) Stock Analysis: A Healthcare Leader with a Robust 15.7% Revenue Growth 19 December 2025
Avadel Pharmaceuticals plc (AVDL) Stock Report: Understanding the 54.9% Revenue Growth Amidst Market Challenges 19 December 2025
STAAR Surgical Company (STAA) Stock Analysis: Navigating Growth with a 10.58% Upside Potential 19 December 2025
Beta Bionics, Inc. (BBNX) Stock Analysis: Growth Potential and Analyst Consensus Point to an 11.15% Upside 19 December 2025
Weave Communications, Inc. (WEAV) Stock Analysis: Potential 47% Upside in the Health Information Services Sector 19 December 2025
ICG Enterprise, Intermediate Capital Group ICGT: friends with benefits (Analyst Interview) 13 January 2022
Dialight plc ultra efficient Vigilant LED High Bay game changer on multiple levels (Interview) 10 January 2022
Babcock International Positioned for Growth with Strong Financials and Market Focus – Shore Capital 6 November 2024
Marks and Spencer deliver increases in market share, profit and returns in H1 results 6 November 2024
Strix Group share price “could bounce back as we get strong earnings this year “says Zeus Capital (LON:KETL) 10 February 2022
Cizzle Biotechnology commercial & royalty agreement represents a very significant deal for the company (LON:CIZ) 9 February 2022
Quadrise Fuels International test results will support and hopefully accelerate the plans on the larger scale trials (LON:QFI) 9 February 2022
JTC Group “delivering organic revenue growth at the top end of its guidance” says Zeus Capital 16 September 2020
SimplyBiz Group “to provide investors with higher than market earnings growth” says Zeus Capital 16 September 2020
City of London Investment Group results beat Zeus Capital’s revenue forecast by 4.1% 15 September 2020
Surface Transforms “well positioned to deliver for the medium-term” says Zeus Capital 15 September 2020
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Real Estate Credit Investments Gains Strong Shareholder Backing Following 2025 Continuation Vote (LON:RECI) 14 January 2026
Surface Transforms FY25 update: Revenue up 120% as manufacturing improvements progress 19 January 2026
Ferro-Alloy Resources agrees MOU with Master Tyre for new carbon black substitute supply 19 January 2026
FirstGroup PLC (FGP.L) Stock Analysis: Exploring a 35% Upside Potential with Strong Buy Ratings 20 January 2026
Auction Technology Group PLC (ATG.L) Stock Analysis: Navigating the 26.51% Upside Potential 20 January 2026
Hilton Food Group PLC (HFG.L) Investor Outlook: 52.39% Potential Upside Highlights Growth Prospects 20 January 2026
Baltic Classifieds Group PLC (BCG.L) Stock Analysis: Unlocking a Potential 41% Upside 20 January 2026
